Journal Article

II.2 Haemodialysis dose quantification: middle molecules (MM)

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 17, issue suppl_7, pages 21-23
Published in print July 2002 | ISSN: 0931-0509
Published online July 2002 | e-ISSN: 1460-2385 | DOI: http://dx.doi.org/10.1093/ndt/17.suppl_7.21
II.2 Haemodialysis dose quantification: middle molecules (MM)

Show Summary Details

Preview

Guideline II.2.1

A. β 2‐m is representative in its kinetic behaviour of other MM and peptides of similar size, and may be used as a marker for such molecules.

(Evidence level: B)

Guideline II.2.2

A. To enhance MM removal, synthetic high‐flux membranes should be used. Additional strategies, such as adding a convective component, or increasing HD time or frequency, should be used to maximize MM removal.

(Evidence level: B)

Journal Article.  0 words. 

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.